Effects of triterpenes on the immune system

Journal of Ethnopharmacology

Volumn 128, Issue 1, 2010, Pages 1-14

  Ríos, José Luis ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Hypersensitivity; Immune diseases; Immunomodulatory agents; Transcription factors; Triterpenoids

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ASTRAGALOSIDE I; ASTRAGALOSIDE II; ASTRAGALOSIDE IV; ASTRAGALOSIDE VI; ASTRASIEVERSIANIN II; ASTRASIEVERSIANIN X; BOSWELLIC ACID; BRYONOLIC ACID; CELASTROL; CUCURBITACIN; CUCURBITACIN R; DIHYDROCUCURBITACIN B; GINSENOSIDE; GINSENOSIDE RF; GINSENOSIDE RG 3; GINSENOSIDE RH 2; GLYCYRRHETINIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NORZEYLASTERAL; OLEANOLIC ACID; PODOCARPASIDE; PREDNISONE; STAT PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; TRITERPENE; TRITERPENE DERIVATIVE; TRITERPENOID; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUTE GRAFT REJECTION; ASTHMA; CONTACT ALLERGY; CONTACT DERMATITIS; CROHN DISEASE; DELAYED HYPERSENSITIVITY; DOSE RESPONSE; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; EAR DISEASE; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; INFLAMMATION; KIDNEY GRAFT REJECTION; LUPUS VULGARIS; NONHUMAN; PASSIVE SKIN ANAPHYLAXIS; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATOID ARTHRITIS; SWELLING; ULCERATIVE COLITIS;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTI-HIV AGENTS; HUMANS; IMMUNE SYSTEM; TRANSCRIPTION FACTORS; TRITERPENES;

EID: 76749137504     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2009.12.045     Document Type: Review

References (47)

1. Abbas A.K., Lichtman A.H. Cellular and Molecular Immunology 2003, Elsevier, Amsterdam.
2. Ali Z., Khan S.I., Ferreira D., Khan I.A. Podocarpaside, a triterpenoid possessing a new backbone from Actaea podocarpa. Organic Letters 2006, 8:5529-5532.
3. Ammon H.P. Boswellic acids in chronic inflammatory diseases. Planta Medica 2006, 72:1100-1116.
4. Bae E.A., Han M.J., Shin Y.W., Kim D.H. Inhibitory effects of Korean red ginseng and its genuine constituents ginsenosides Rg3, Rf, and Rh2 in mouse passive cutaneous anaphylaxis reaction and contact dermatitis models. Biological and Pharmaceutical Bulletin 2006, 29:1862-1867.
5. Behboudi S., Morein B., Villacres-Eriksson M. In vitro activation of antigen-presenting cells (APC) by defined composition of Quillaja saponaria Molina triterpenoids. Clinical and Experimental Immunology 1996, 105:26-30.
6. Behboudi S., Morein B., Villacres-Eriksson M. In vivo and in vitro induction of IL-6 by Quillaja saponaria Molina triterpenoid formulations. Cytokine 1997, 9:682-687.
7. Blaskovich M.A., Sun J., Cantor A., Turkson J., Jove R., Sebti S.M. Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. Cancer Research 2003, 63:1270-1279.
8. Brinker A.M., Ma J., Lipsky P.E., Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 2007, 68:732-766.
9. Butler M.S. Natural products to drugs: natural products-derived compounds in clinical trials. Natural Product Reports 2008, 25:475-516.
10. Çalis I., Yürüker A., Taşdemir D., Wright A.D., Sticher O., Luo Y.D., Pezzuto J.M. Cycloartane triterpene glycosides from the roots of Astragalus melanophrurius. Planta Medica 1997, 63:183-186.
11. Calixto J.B., Otuki M.F., Santos A.R.S. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor κB (NF-κB). Planta Medica 2003, 69:973-983.
12. Chai H., Wang Q., Huang L., Xie T., Fu Y. Ginsenoside Rb1 inhibits tumor necrosis factor-α-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Biological and Pharmaceutical Bulletin 2008, 31:2050-2056.
13. Chiang L.C., Ng L.T., Chiang W., Chang M.Y., Lin C.C. Immunomodulatory activities of flavonoids, monoterpenoids, triterpenoids, iridoid glycosides and phenolic compounds of Plantago species. Planta Medica 2003, 69:600-604.
14. Delves P., Martin S., Burton D., Roitt I. Roitt's Essential Immunology 2006, Wiley-Blackwell, Hoboken, NJ, USA. 11th ed.
15. Dirsch V.M., Kiemer A.K., Wagner H., Vollmar A.M. The triterpenoid quinonemethide pristimerin inhibits induction of inducible nitric oxide synthase in murine macrophages. European Journal of Pharmacology 1997, 336:211-217.
16. Escandell J.M., Recio M.C., Máñez S., Giner R.M., Cerdá-Nicolás M., Ríos J.L. Dihydrocucurbitacin B, isolated from Cayaponia tayuya, reduces damage in adjuvant-induced arthritis. European Journal of Pharmacology 2006, 532:145-154.
17. Escandell J.M., Recio M.C., Máñez S., Giner R.M., Cerdá-Nicolás M., Ríos J.L. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in Lewis rats by suppression of TNF-α in T lymphocytes and macrophages. Journal of Pharmacology and Experimental Therapeutics 2007, 320:581-590.
18. Escandell J.M., Recio M.C., Máñez S., Giner R.M., Cerdá-Nicolás M., Gil-Benso R., Ríos J.L. Dihydrocucurbitacin B inhibits delayed-type hypersensitivity reaction by suppressing lymphocyte proliferation. Journal of Pharmacology and Experimental Therapeutics 2007, 322:1261-1268.
19. Escandell J.M., Recio M.C., Giner R.M., Máñez S., Cerdá-Nicolás M., Merfort I., Ríos J.L. Inhibition of delayed-type hypersensitivity by cucurbitacin R through the curving of lymphocyte proliferation and cytokine expression by means of NF-AT translocation to the nucleus. Journal of Pharmacology and Experimental Therapeutics 2010, 332:352-363.
20. Frei B., Heinrich M., Herrmann D., Orjala J.E., Schmitt J., Sticher O. Phytochemical and biological investigation of Begonia heracleifolia. Planta Medica 1998, 64:385-386.
21. Fujimoto H., Nakayama M., Nakayama Y., Yamazaki M. Isolation and characterization of immunosuppressive components of three mushrooms, Pisolithus tinctorius, Microporus flabelliformis and Lenzites betulina. Chemical and Pharmaceutical Bulletin 1994, 42:694-697.
22. Giner-Larza E.M., Máñez S., Recio M.C., Giner R.M., Ríos J.L. A review on the pharmacology of lanostanes and related tetracyclic triterpenes. Research Advances in Phytochemistry 2000, 65-82. Global Research Network, Trivandrum (India). R.M. Mohan (Ed.).
23. Haridas V., Arntzen C.J., Gutterman J.U. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-κB by inhibiting both its nuclear localization and ability to bind DNA. Proceeding of the Natural Academy of Sciences USA 2001, 98:11557-11562.
24. Khajuria A., Gupta A., Garai S., Wakhloo B.P. Immunomodulatory effects of two sapogenins 1 and 2 isolated from Luffa cylindrica in Balb/C mice. Bioorganic and Medicinal Chemistry Letters 2007, 17:1608-1612.
25. Kim S.M., Lee S.Y., Yuk D.Y., Moon D.C., Choi S.S., Kim Y., Han S.B., Oh K.W., Hong J.T. Inhibition of NF-κB by ginsenoside Rg3 enhances the susceptibility of colon cancer cells to docetaxel. Archives of Pharmacal Research 2009, 32:755-765.
26. Kim B.H., Lee Y.G., Park T.Y., Kim H.B., Rhee M.H., Cho J.Y. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1β production via suppression of the NF-κB pathway. Planta Medica 2009, 75:321-326.
27. Kroes B.H., Beukelman C.J., van den Berg A.J., Wolbink G.J., van Dijk H., Labadie R.P. Inhibition of human complement by β-glycyrrhetinic acid. Immunology 1997, 90:115-120.
28. Lee J.H., Koo T.H., Yoon H., Jung H.S., Jin H.Z., Lee K., Hong Y.S., Lee J.J. Inhibition of NF-κB activation through targeting IκB kinase by celastrol, a quinone methide triterpenoid. Biochemical Pharmacology 2006, 72:1311-1321.
29. Li X.W., Weir M.R. Radix Tripterygium wilfordii-a Chinese herbal medicine with potent immunosuppressive properties. Transplantation 1990, 50:82-86.
30. Moradali M.-F., Mostafavi H., Ghods S., Hedjaroude G.-A. Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). International Immunopharmacology 2007, 7:701-724.
31. Oh S.R., Kinjo J., Shii Y., Ikeda T., Nohara T., Ahn K.S., Kim J.H., Lee H.K. Effects of triterpenoids from Pueraria lobata on immunohemolysis: β-d-glucuronic acid plays an active role in anticomplementary activity in vitro. Planta Medica 2000, 66:506-510.
32. Panossian A., Gabrielian E., Wagner H. Plant adaptogens II. Bryonia as an adaptogen. Phytomedicine 1997, 4:83-97.
33. Panossian A., Gabrielian E., Wagner H. On the mechanism of action of plant adaptogens with particular reference to cucurbitacin R diglucoside. Phytomedicine 1999, 6:147-155.
34. Pfitzner E., Kliem S., Baus D., Littnerst C.M. The role of STATs in inflammation and inflammatory diseases. Current Pharmaceutical Design 2004, 10:2839-2850.
35. Ríos J.L. Ganoderma lucidum, un hongo con potenciales propiedades inmunoestimulantes. Revista de Fitoterapia 2008, 8:135-146.
36. Ríos J.L., Bas E., Recio M.C. Effects of natural products on contact dermatitis. Current Medicinal Chemistry. Anti-inflammatory and Anti-allergic Agents 2005, 4:65-80.
37. Ríos J.L., Giner R.M., Jiménez M.J., Hancke J.L., Wickman G. Studies on the anti-inflammatory activity of Cayaponia tayuya root. Fitoterapia 1990, 61:275-278.
38. Ríos J.L., Recio M.C., Escandell J.M., Andújar I. Inhibition of transcription factors by plant-derived compounds and their implications in inflammation and cancer. Current Pharmaceutical Design 2009, 15:1212-1237.
39. Ríos J.L., Waterman P.G. A review on the pharmacology and toxicology of Astragalus. Phytotherapy Research 1997, 11:411-418.
40. Safayhi H., Rall B., Sailer E.R., Ammon H.P. Inhibition by boswellic acids of human leukocyte elastase. Journal of Pharmacology and Experimental Therapeutics 1997, 281:460-463.
41. Scholz D., Baumann K., Grassberger M., Wolff-Winiski B., Rihs G., Walter H., Meingassner J.G. Synthesis of dammarane-type triterpenoids with anti-inflammatory activity in vivo. Bioorganic and Medicinal Chemistry Letters 2004, 14:2983-2986.
42. Sethi G., Ahn K.S., Pandey M.K., Aggarwal B.B. Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-κB-regulated gene products and TAK1-mediated NF-κB activation. Blood 2007, 109:2727-2735.
43. Sun J., Blaskovich M.A., Jove R., Livingston S.K., Coppola D., Sebti M. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity. Oncogene 2005, 24:3236-3245.
44. Thimmulappa R.K., Fuchs R.J., Malhotra D., Scollick C., Traore K., Bream J.H., Trush M.A., Liby K.T., Sporn M.B., Kensler T.W., Biswal S. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxidant and Redox Signaling 2007, 9:1963-1970.
45. Won J.H., Im H.T., Kim Y.H., Yun K.J., Park H.J., Choi J.W., Lee K.T. Anti-inflammatory effect of buddlejasaponin IV through the inhibition of iNOS and COX-2 expression in RAW 264.7 macrophages via the NF-κB inactivation. British Journal of Pharmacology 2006, 148:216-225.
46. Xu W., Lin Z., Yang C., Zhang Y., Wang G., Xu X., Lv Q., Ren Y., Dong Y. Immunosuppressive effects of demethylzeylasteral in a rat kidney transplantation model. International Immunopharmacology 2009, 9:996-1001.
47. Yu D., Morris-Natschke S.L., Lee K.H. New developments in natural products-based anti-AIDS research. Medicinal Research Reviews 2007, 27:108-132.